A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries.
Cyanotic heart defects, which account for approximately 25% of all CHDs, include:
Tetralogy of Fallot (ToF)
Total anomalous pulmonary venous connection
Hypoplastic left heart syndrome (HLHS)
Transposition of the great arteries (d-TGA)
Truncus arteriosus (Persistent)
Tricuspid atresia
Interrupted aortic arch
Pulmonary atresia (PA)
Pulmonary stenosis (critical)
Eisenmenger syndrome(Reversal of Shunt due to Pulmonary Hypertension) .
Patent ductus arteriosus may cause cyanosis in late stage.
A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries.
Cyanotic heart defects, which account for approximately 25% of all CHDs, include:
Tetralogy of Fallot (ToF)
Total anomalous pulmonary venous connection
Hypoplastic left heart syndrome (HLHS)
Transposition of the great arteries (d-TGA)
Truncus arteriosus (Persistent)
Tricuspid atresia
Interrupted aortic arch
Pulmonary atresia (PA)
Pulmonary stenosis (critical)
Eisenmenger syndrome(Reversal of Shunt due to Pulmonary Hypertension) .
Patent ductus arteriosus may cause cyanosis in late stage.
commonly used for medical students, and helpful to use this ppt to study for them, and also a common man can understand very easily what is coarctation of aorta.
Transposition of the great arteries is a serious but rare heart defect present at birth (congenital), in which the two main arteries leaving the heart are reversed (transposed). The condition is also called dextro-transposition of the great arteries.
Some babies with tricuspid atresia have other conditions, such as pulmonary stenosis or transposition of the great arteries, that also affect blood flow through their heart. These conditions require treatment, too.
A congenital heart defect is a problem with the structure of the heart. It is present at birth. Congenital heart defects are the most common type of birth defect. The defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. They can disrupt the normal flow of blood through the heart. The blood flow can slow down, go in the wrong direction or to the wrong place, or be blocked completely.
Doctors use a physical exam and special heart tests to diagnose congenital heart defects. They often find severe defects during pregnancy or soon after birth. Signs and symptoms of severe defects in newborns include
Rapid breathing
Cyanosis - a bluish tint to the skin, lips, and fingernails
Fatigue
Poor blood circulation
Many congenital heart defects cause few or no signs and symptoms. They are often not diagnosed until children are older.
Many children with congenital heart defects don't need treatment, but others do. Treatment can include medicines, catheter procedures, surgery, and heart transplants. The treatment depends on the type of the defect, how severe it is, and a child's age, size, and general health.
ACYANOTIC DISEASE- Non cyanotic heart diseasesNelsonNgulube
ETIOLOGY AND EPIDEMIOLOGY
Congenital heart disease occurs in 8 per 1,000 births. The spectrum of lesions ranges from asymptomatic to fatal. Although most cases of congenital heart disease are multifactorial, some lesions are associated with chromosomal disorders, single gene defects, teratogens, or maternal metabolic disease (see Table139-2).
Congenital heart defects can be divided into three pathophysiological groups (Table 143.1).
1. Left-to-right shunts
2. Right-to-left shunts
3. Obstructive, stenotic lesions
Acyanotic congenital heart disease includes left-to-right shunts resulting in an increase in pulmonary blood flow (patent ductus arteriosus [PDA], ventricular septal defect [VSD], atrial septal defect [ASD]) and obstructive lesions (aortic stenosis, pulmonary stenosis, coarctation of the aorta), which usually have normal pulmonary blood flow.
VENTRICULAR SEPTAL DEFECTEtiology and Epidemiology
The ventricular septum is a complex structure that can be divided
into four components. The largest component is the muscular
septum. The inlet or posterior septum comprises endocardial
cushion tissue. The subarterial or supracristal septum com
prises conotruncal tissue. The membranous septum is below
the aortic valve and is relatively small. VSDs occur when any of these components fail to develop normally (Fig. 143.1). VSD,
the most common congenital heart defect, accounts for 25% of all congenital heart disease. Perimembranous VSD
commonly used for medical students, and helpful to use this ppt to study for them, and also a common man can understand very easily what is coarctation of aorta.
Transposition of the great arteries is a serious but rare heart defect present at birth (congenital), in which the two main arteries leaving the heart are reversed (transposed). The condition is also called dextro-transposition of the great arteries.
Some babies with tricuspid atresia have other conditions, such as pulmonary stenosis or transposition of the great arteries, that also affect blood flow through their heart. These conditions require treatment, too.
A congenital heart defect is a problem with the structure of the heart. It is present at birth. Congenital heart defects are the most common type of birth defect. The defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. They can disrupt the normal flow of blood through the heart. The blood flow can slow down, go in the wrong direction or to the wrong place, or be blocked completely.
Doctors use a physical exam and special heart tests to diagnose congenital heart defects. They often find severe defects during pregnancy or soon after birth. Signs and symptoms of severe defects in newborns include
Rapid breathing
Cyanosis - a bluish tint to the skin, lips, and fingernails
Fatigue
Poor blood circulation
Many congenital heart defects cause few or no signs and symptoms. They are often not diagnosed until children are older.
Many children with congenital heart defects don't need treatment, but others do. Treatment can include medicines, catheter procedures, surgery, and heart transplants. The treatment depends on the type of the defect, how severe it is, and a child's age, size, and general health.
ACYANOTIC DISEASE- Non cyanotic heart diseasesNelsonNgulube
ETIOLOGY AND EPIDEMIOLOGY
Congenital heart disease occurs in 8 per 1,000 births. The spectrum of lesions ranges from asymptomatic to fatal. Although most cases of congenital heart disease are multifactorial, some lesions are associated with chromosomal disorders, single gene defects, teratogens, or maternal metabolic disease (see Table139-2).
Congenital heart defects can be divided into three pathophysiological groups (Table 143.1).
1. Left-to-right shunts
2. Right-to-left shunts
3. Obstructive, stenotic lesions
Acyanotic congenital heart disease includes left-to-right shunts resulting in an increase in pulmonary blood flow (patent ductus arteriosus [PDA], ventricular septal defect [VSD], atrial septal defect [ASD]) and obstructive lesions (aortic stenosis, pulmonary stenosis, coarctation of the aorta), which usually have normal pulmonary blood flow.
VENTRICULAR SEPTAL DEFECTEtiology and Epidemiology
The ventricular septum is a complex structure that can be divided
into four components. The largest component is the muscular
septum. The inlet or posterior septum comprises endocardial
cushion tissue. The subarterial or supracristal septum com
prises conotruncal tissue. The membranous septum is below
the aortic valve and is relatively small. VSDs occur when any of these components fail to develop normally (Fig. 143.1). VSD,
the most common congenital heart defect, accounts for 25% of all congenital heart disease. Perimembranous VSD
The lecture is for medical student. It is from Dr RUSINGIZA Emmanuel, MD, senior lecture at UR( UNIVERSITY OF RWANDA) .
It will help to understand heart diseases in newborn, infants and children.
Similar to Ventricular Septal Defect with Nursing Management (20)
Small intestine perforation- Easy ppt for student nurses
definition
causes
clinical manifestations
diagnostic tests
management of small intestine perforation
Introduction to Nursing-
Concept
Meaning
Definition of Nursing-
1. According to Florence Nightingale
2. According to American Nurses Association
Scope of Nursing
Aims of Nursing
Roles, Responsibilities and functions of nursing
Review of lungs anatomy and physiology- Easy explanation for students
Introduction
Anatomy
Air movement through Lungs
Physiology of Respiration
Assessment of Respiratory System
Types of bed in Nursing- easy explanation for Student Nurses
CLOSED BED
OPEN BED
ADMISSION BED
OCCUPIED BED
OPERATION BED/POST ANESTHESIA BED/RECOVERY BED
CARDIAC BED
FRACTURE BED
AMPUTATION BED/STUMP BED
BURN BED
Cancer of Breast - easy ppt for Nursing Students
Definition
Risk factors
Clinical manifestations
Assessment & diagnostic findings
Management
Surgery
Breast cancer rehabilitation
Pharyngitis- Easy PPT for Nursing StudentsSwatilekha Das
Pharyngitis- Easy PPT for Nursing Students
organs of the respiratory system
Definition
Acute Pharyngitis definition
Causes
Clinical features
Diagnosis
Treatment
Nutritional therapy
Chronic Pharyngitis
types
Clinical manifestations
Medical management
Cancer of Prostate- Easy PPT for Nursing StudentsSwatilekha Das
Cancer of Prostate- Easy PPT for Nursing Students
Definition & picture
Risk factors
Clinical manifestations
Assessment & diagnostic methods
Medical management
Surgical Management
-Radical prostatectomy
Radiation therapy
Hormone therapy
Other therapies
Thank you
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Excluding biscuspid aortic valves, ventricular septal
defects (VSDs) are the most common congenital
cardiac lesion, occurring in isolation or in association
with other congenital cardiac defects.
The ventricular septum is divided into four
components, the trabecular or muscular septum
extending to the apex, the inlet (posterior) septum
between the atrioventricular valves, the outlet septum
which subtends the great arteries and the membranous
septum which lies under the aortic root. Defects can
arise in any position but the membraneous septum is
most commonly affected.
3. The ventricular septum forms the medial wall and
normally bulges in to the right ventricle. It is almost
muscular except for the superiorly located
membraneous septum just below the right and
posterior (noncoronary) cusps of te aortic valve. On the
left ventricular side the demarcation between the
membraneous septum and the muscular septum is
called limbus marginalis.
The membranous septum is both interventricular and
atrioventricular. The former portion lies between the
left ventricle and the right ventricle. The latter,
superior, part of the membraneous septum lies
between the left atrium and the right atrium.
5. A ventricular septal defect is an opening in the
interventricular septum that permits
communication between the two ventricles.
or
A VSD is an opening or hole (defect) in the wall
(septum) between the heart’s two pumping
chambers (ventricles).
7. Before a baby is born, the right and left ventricles of its heart are
not separate. As the fetus grows, a wall forms to separate these two
ventricles. If the wall does not completely form, a hole remains.
This hole is known as a ventricular septal defect, or a VSD.
Ventricular septal defect is one of the most common congenital
heart defects. The baby may have no symptoms, and the hole can
eventually close as the wall continues to grow after birth. If the
hole is large, too much blood will be pumped to the lungs, leading
to heart failure.
The cause of VSD is not yet known. This defect often occurs along
with other congenital heart defects.
In adults, ventricular septal defects are a rare but serious
complication of heart attacks. These holes do not result from a birth
defect.
9. Defects of the ventricular septum, which may be large in relation to the
size of the heart at birth, tend to become smaller or to close in early
childhood. If closure is insufficient to prevent a large shunt, the small
pulmonary vessels may be damaged by being exposed to the ejectile
force and pressure of left ventricular contraction. Irreversible
pulmonary hypertension may be produced.
The effect of a ventricular septal defect (VSD) depends upon its size
and upon the impedance to blood flow imposed by the pulmonary
arterial vessels.
If the defect is small, the jet of blood from the high pressure left
ventricle to the low-pressure right ventricle has little hemodynamic
effect.
If the defect is large and the impedance of the pulmonary vessels low, a
large shunt develops and the pulmonary blood flow becomes
substantially more than systemic. If , on the other hand, there is a high
pulmonary vascular resistance, the pulmonary blood flow is little or no
more than the systemic and the pressure in both circuits is similar. If the
pulmonary vascular resistance is very high, the shunt reverses (the so
called Eisenmenger Complex).
11. Symptoms
In VSD the patient with a small defect, there are no symptoms,
but there is a loud ‘tearing’ pansystolic murmur often
accompanied by a thrill, maximal to the left side of the lower
sternum.
Newborn infants have a high pulmonary vascular resistance
which falls to normal levels in the first 3 months of life. At this
point, a large defect at ventricular level is liable to produced
cardiac failure and require treatment.
12. Signs
Cardiac failure is usually obvious in the infant or
small child with a significant left to right shunt
through a large VSD.
In the presence of a large left to right shunt the
pulse is usually small and the venous pressure
normal, unless there is right heart failure.
Both left and right ventricles may be
hyperdynamic and with a large shunt, a soft
pansystolic murmur is heard at the lower sternal
edge, usually accompanied by a mid-diastolic
murmur at the apex due to high flow through the
mitral valve,
13. Although there are some patients in whom large
defects get smaller and become restrictive to flow,
most, if untreated will ultimately progress to
irreversible pulmonary hypertension as a result of
pulmonary vascular disease.
The development of pulmonary vascular disease is
often heralded by an improvement in the
symptoms of cardiac failure as the resistance to
follow through the lungs decreases flow.
Right ventricular hypertrophy is evident, the
pulmonary second sound may be accentuated and
followed by the early diastolic murmur of
pulmonary regurgitation.
14. HISTORY-
Infants with larger defects develop heart failure, usually by 3 months
of age. Parents may note tachypnea, fatigue with feedings, poor
weight gain and excessive sweating. Infants and children with small
ventricular defects are asymptomatic; their defects are ordinarily
detected early by routine examination because of the loudness of the
murmur.
PHYSICAL EXAMINATION-
Typical loud, harsh holosystolic murmur
Middiastole rumble
Pulmonary rales and peripheral edema
The second heart sound is loud and single
cyanosis
CHEST X-RAY
It is normal with a small defect, but with a large left to right shunt
there is some enlargement of the heart and, more specifically ,
prominence of the pulmonary vessels, left atrium and both ventricles.
15. ECG
The ECG in small defects is normal. When the left to right shunt is large, there
is usually evidence of biventricular enlargement, manifested by abnormally
deep but narrow Q waves and tall R waves in the left chest leads. In cases
with pulmonary vascular disease, the ECG pattern of isolated right ventricular
hypertrophy develops. Large defects may involve the conducting tissue and
left axis deviation occurs.
ECHOCARDIOGRAPHY
Two-dimensional echocardiography, along with Doppler echocardiography
and colour flow imaging can assess the size and location of virtually all
ventricular septal defects (VSDs). Doppler echocardiography also provides
physiological information including right ventricular pressure, pulmonary
artery pressure and the difference in pressure between the ventricles.
Measurement of left atrial and left ventricular diameter provides semi-
quantitative information about shunt volume.
CARDIAC CATHETERIZATION
There is a step-up in oxygen saturation at the right ventricular level. The
degree of pulmonary hypertension can be measured, and pulmonary vascular
resistance should be calculated. Selective biplane cineangiography in the left
ventricle will outline the defect.
1. Establish diagnosis
2. Determine type and severity
3. Confirm and exclude associated lesions
16. Medications
With a small lesion the prognosis is excellent and no intervention
is required beyond antibiotic prophylaxis where indicated.
In moderate size lesions a trial of furosemide, angiotensin-
converting enzyme (ACE) inhibitor and digoxin may work.
Large lesions with a big shunt usually require medical
management for heart failure with diuretics ± ACE inhibitors.
Otherwise surgical closure is required before vascular disease
compromises the surgical outcome – usually within the first 6-12
months of life
Surgical repair is required if:
There is uncontrolled heart failure, including poor growth. Even very
small babies may be considered.
If the pulmonary artery pressure is raised then repair may be considered
before the first birthday.
Even with normal pulmonary artery pressure, if the ratio of aortic flow:
pulmonary flow exceeds 2:1, then repair is required.
17. Palliative:
Pulmonary artery banding (placing a band around
the main pulmonary artery to decease pulmonary
blood flow) in infants in severe CHF. It is unusual
because of the improvement of the surgical
techniques.
Complete repair(procedure of choice):
Small defects are repaired with a purse-string
approach.
Large defects usually require a knitted Dacron
patch sewn over the opening. Both procedures are
performed via cardiopulmonary bypass. The
repair is generally approached through the right
atrium and the tricuspid valve.
18. Except for VSD that is caused by a heart attack,
this condition is always present at birth.
Drinking alcohol and using the antiseizure
medicines depakote and dilantin during
pregnancy may increase the risk of VSDs.
Other than avoiding these things during
pregnancy, there is no known way to prevent a
VSD.
19. Aortic insufficiency (leaking of the valve that separates the left ventricle
from the aorta)
Damage to the electrical conduction system of the heart during surgery
(causing an irregular heart rhythm)
Delayed growth and development (failure to thrive in infancy)
Heart failure
Infective endocarditis (bacterial infection of the heart)
Pulmonary hypertension (high blood pressure in the lungs) leading to
failure of the right side of the heart
Postoperative problems can occur:
A small residual ventricular septal defect (VSD) (not uncommon).
Depending upon heart size, symptoms and degree of shunting it may be
necessary to re-operate.
Right bundle branch block may be caused by operative trauma, and
occasionally complete heart block can occur. This has a late mortality.
Ventricular dysfunction and ventricular arrhythmia can be a problem.
20. Nursing diagnosis
Cough related to lung congestion secondary to the
effect of general anesthesia
Goal
Reduce the coughing of the patient
Interventions
Assess the patient for coughing
Auscultate chest of the patient with pediatric
stethoscope
Give chest physiotherapy.
Give nebulisation with Levolin as dose of ¼ resp.
Auscultate . after giving nebulization
Expected outcomes
Coughing will be reduced.
21. Nursing diagnosis
High risk for fall related to the age and weakness
of the child
Goal
Reduce the chances of fall
Interventions
Assess the chances of getting fall.
Provide side rails to prevent fall.
Provide calling bell for the patient.
Allow the mother to stay with the patient.
Do close observation of the patient.
Expected outcomes
No fall of the patient will be there.
22. Nursing diagnosis
Pain related to the surgical wound as evidenced by
facial pain scale
Goal
Reduce pain
Interventions
Assess the location & source of pain.
Assess the severity of pain.
Assess the patient from facial expression as per
pediatric pain scale.
Provide comfortable position.
Administer oral analgesics (Syrup Ibugesic plus)
2.5ml as ordered by physician.
Expected outcomes
Pain will be reduced.
23. Nursing diagnosis
High risk for infection related to the presence of
surgical wound
Goal
Reduce risk of getting infection.
Interventions
Assess patient for signs of infection.
Maintain aseptic technique during any procedure.
Do hand washing before and after each procedure,
touching patient.
Check temperature every 4 hourly and SOS.
Administer prescribed antibiotics (Syrup Augmentin
Duo) 2.5ml as prescribed by physician.
Check vital signs and record it.
Expected outcomes
No infection will be present.
24. Nursing diagnosis
Knowledge deficit of parents of the child related to
the disease process as evidenced by frequent
questioning
Goal
Increase knowledge level of the parents.
Interventions
Assess the knowledge level of the parents of the
patient.
Provide information about disease process of the
patient.
Clear doubts of the parents.
Explain about medicines, diet, comfort and sleep,
wound care and follow up care.
Take feedback from the parents.
Expected outcomes
Knowledge level of the parents will be increased.
25. Nursing diagnosis
Anxiety of parents related to the disease process,
treatment regimen, hospital stay as evidenced by
facial expression and verbalization
Goal
Reduce anxiety of the parents.
Interventions
Assess the anxiety level of the parents.
Provide information about disease process,
treatment regimen, and hospital stay.
Give psychological support to the parents.
Counsel the parents if needed.
Expected outcomes
Anxiety of the parents will be reduced.
26. Fortunately most ventricular septal defects are
small. Many become smaller close spontaneously
during childhood. Among patients with large
defects congestive heart failure is likely in infancy
and causes death unless managed appropriately.